Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Nancy CEDEX, France Clinical Trials

A listing of Nancy CEDEX, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

Management of Paroxystic Atrial Fibrillation in French Intensive Care Units

Atrial fibrillation (AF) is a common arrhythmia in the ICU and is associated with significant morbidity. However, curative treatment remains unclearly established. In fact, there are no specific recommendations for new onset atrial fibrillation in ICU and only few studies have assessed this topic. The PAF-ICU trial is an observational, ...

Phase N/A

0.0 miles

Learn More »

Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects ( 45 Years) Hospitalized for an Ischaemic Stroke

Incidence of strokes has increased these last 20 years in young population. This rise could be linked to alcohol, tobacco or drug use like cannabis. Cannabis has previously been descripted as a potential factor of reversible vasoconstriction. The main objective is to show that an exhaustive assessment of a stroke ...

Phase N/A

0.0 miles

Learn More »

Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block Failure

Paravertebral Block (PVB) combined with general anesthesia (GA) is a conventional pain treatment for breast surgery but sometimes failures can occurs. The efficacy of this block has to be evaluated. Also, for the intra-operative analgesic evaluation of this block, it is necessary to measure intra-operative analgesia index. A monitor of ...

Phase N/A

2.19 miles

Learn More »

UNUSUAL TOXICITY INDUCED BY RADIOTHERAPY STUDY

In order to evaluate the physiopathological knowledge of the different pathological manifestations associated with individual radiosensitivity, it seems essential to carry out this pilot study. It has agglomerated homogeneous tissue samples to identify new biomarkers for patient diagnosis and follow-up, and may predict the therapeutic response. These knowledge will help ...

Phase N/A

2.24 miles

Learn More »